Pilot study of gemtuzumab ozogamicin, liposomal daunorubicin, cytarabine and cyclosporine regimen in patients with refractory acute myelogenous leukemia

Efrosyni Apostolidou, Jorge Cortes, Apostolia Tsimberidou, Elihu Estey, Hagop Kantarjian, Francis J. Giles

Research output: Contribution to journalArticlepeer-review

54 Scopus citations

Fingerprint

Dive into the research topics of 'Pilot study of gemtuzumab ozogamicin, liposomal daunorubicin, cytarabine and cyclosporine regimen in patients with refractory acute myelogenous leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences